Literature DB >> 15530430

COBRA1 inhibits AP-1 transcriptional activity in transfected cells.

Hongjun Zhong1, Jianhua Zhu, Hao Zhang, Lihua Ding, Yan Sun, Cuifen Huang, Qinong Ye.   

Abstract

Mutations in the breast cancer susceptibility gene (BRCA1) account for a significant proportion of hereditary breast and ovarian cancers. Cofactor of BRCA1 (COBRA1) was isolated as a BRCA1-interacting protein and exhibited a similar chromatin reorganizing activity to that of BRCA1. However, the biological role of COBRA1 remains largely unexplored. Here, we report that ectopic expression of COBRA1 inhibited activator protein 1 (AP-1) transcriptional activity in transfected cells in a dose-dependent manner, whereas reduction of endogenous COBRA1 with a small interfering RNA significantly enhanced AP-1-mediated transcriptional activation. COBRA1 physically interacted with the AP-1 family members, c-Jun and c-Fos, and the middle region of COBRA1 bound to c-Fos. Lack of c-Fos binding site in the COBRA1 completely abolished the COBRA1 inhibition of AP-1 trans-activation. These findings suggest that COBRA1 may directly modulate AP-1 pathway and, therefore, may play important roles in cell proliferation, differentiation, apoptosis, and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530430     DOI: 10.1016/j.bbrc.2004.10.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Enforcing the pause: transcription factor Sp3 limits productive elongation by RNA polymerase II.

Authors:  Alvaro Valin; Grace Gill
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

2.  Kinetic competition between elongation rate and binding of NELF controls promoter-proximal pausing.

Authors:  Jian Li; Yingyun Liu; Ho Sung Rhee; Saikat Kumar B Ghosh; Lu Bai; B Franklin Pugh; David S Gilmour
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

Review 3.  Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation.

Authors:  Sergei Nechaev; Karen Adelman
Journal:  Biochim Biophys Acta       Date:  2010-11-13

4.  NELF-mediated stalling of Pol II can enhance gene expression by blocking promoter-proximal nucleosome assembly.

Authors:  Daniel A Gilchrist; Sergei Nechaev; Chanhyo Lee; Saikat Kumar B Ghosh; Jennifer B Collins; Leping Li; David S Gilmour; Karen Adelman
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

5.  Functional genomics analysis of low concentration of ethanol in human hepatocellular carcinoma (HepG2) cells. Role of genes involved in transcriptional and translational processes.

Authors:  Francisco Castaneda; Sigrid Rosin-Steiner; Klaus Jung
Journal:  Int J Med Sci       Date:  2006-12-21       Impact factor: 3.738

6.  ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis.

Authors:  Qiang Yan; Chenming Ni; Yingying Lin; Xu Sun; Zhenhua Shen; Minjie Zhang; Shuwen Han; Jiemin Shi; Jing Mao; Zhe Yang; Weilin Wang
Journal:  Front Mol Biosci       Date:  2021-12-13

7.  Deregulation of cofactor of BRCA1 expression in breast cancer cells.

Authors:  Jianlong Sun; Gareth Watkins; Ashley L Blair; Christopher Moskaluk; Sagar Ghosh; Wen G Jiang; Rong Li
Journal:  J Cell Biochem       Date:  2008-04-15       Impact factor: 4.429

8.  BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.

Authors:  Huiyoung Yun; Roble Bedolla; Aaron Horning; Rong Li; Huai-Chin Chiang; Tim-H Huang; Robert Reddick; Aria F Olumi; Rita Ghosh; Addanki P Kumar
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.